Implications of sulfotransferase activity in interindividual variability in drug response: clinical perspective on current knowledge

References

• Ahmad, Y., et al., 2015. The proteome of hypobaric induced hypoxic lung: insights from temporal proteomic profiling for biomarker discovery. Scientific reports, 5, 10681.
   PubMed Web of Science ®Google Scholar
• Alnouti, Y. and Klaassen, C.D., 2011. Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults). Xenobiotica, 41 (3), 187–197.
   PubMed Web of Science ®Google Scholar
• Andersson, H., et al., 2010. Tamoxifen-induced adduct formation and cell stress in human endometrial glands. Drug metabolism and disposition, 38 (1), 200–207.
   PubMed Web of Science ®Google Scholar
• Bamforth, K.J., Dalgliesh, K., and Coughtrie, M.W., 1992. Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity? European journal of pharmacology, 228 (1), 15–21.
   PubMed Web of Science ®Google Scholar
• Barrett, K.G., et al., 2016. Transcriptional regulation of cytosolic sulfotransferase 1C2 by vitamin D receptor in LS180 human colorectal adenocarcinoma cells. Drug metabolism and disposition: the biological fate of chemicals, 44 (8), 1431–1434.
   PubMed Web of Science ®Google Scholar
• Bersoff-Matcha, S., Miller, W., and Aberg, J., 2001. Sex differences in nevirapine rash. Clinical infectious diseases, 32, 124–129.
   PubMed Web of Science ®Google Scholar
• Blanchard, R.L., et al., 2004. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics, 14 (3), 199–211.
   PubMedGoogle Scholar
• Borthwick, E.B., Burchell, A., and Coughtrie, M.W.H., 1995. Differential expression of hepatic oestrogen, phenol and dehydroepiandrosterone sulphotransferases in genetically obese diabetic (ob/ob) male and female mice. Journal of endocrinology, 144 (1), 31–37.
   PubMed Web of Science ®Google Scholar
• Chen, B.-H., et al., 2015. Mechanism of sulfotransferase pharmacogenetics in altered xenobiotic metabolism. Expert opinion on drug metabolism & toxicology, 11 (7), 1053–1071.
   PubMed Web of Science ®Google Scholar
• Chen, X., 2007. Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1). Toxicology, 231, 224–233.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Zhang, S., and Zhou, T., 2013. Liver X receptor alpha mediated genistein induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1) in Hep G2 cells. Toxicology and applied pharmacology, 268 (2), 106–112.
   PubMed Web of Science ®Google Scholar
• Choi, J., et al., 2005. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer epidemiology, biomarkers & prevention, 14, 1090–1096.
   PubMed Web of Science ®Google Scholar
• Cook, I., et al., 2012. A nucleotide-gated molecular pore selects sulfotransferase substrates. Biochemistry, 51 (28), 5674–5683.
   PubMed Web of Science ®Google Scholar
• Cook, I., et al., 2013a. High accuracy in silico sulfotransferase models. Journal of biological chemistry, 288 (48), 34494–34501.
   PubMed Web of Science ®Google Scholar
• Cook, I., et al., 2013b. The gate that governs sulfotransferase selectivity. Biochemistry, 52 (2), 415–424.
   PubMed Web of Science ®Google Scholar
• Coughtrie, M., et al., 1999. Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochemical journal, 337(Pt1), 45.
   Web of Science ®Google Scholar
• Coughtrie, M.W., and Johnston, L.E., 2001. Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug metabolism and disposition, 29(4Pt2), 522–528.
   Web of Science ®Google Scholar
• Coughtrie, M.W.H., 2016. Function and organization of the human cytosolic sulfotransferase (SULT) family. Chemico-biological interactions, 259 (Pt A), 2–7.
   PubMed Web of Science ®Google Scholar
• Coughtrie, M.W.H., et al., 1994. Sulfation of endogenous compounds and xenobiotics – Interactions and function in health and disease. Chemico-biological interactions, 92 (1–3), 247–256.
   PubMed Web of Science ®Google Scholar
• Coughtrie, M.W.H., 2002. Sulfation through the looking glass – recent advances in sulfotransferase research for the curious. The pharmacogenomics journal, 2 (5), 297–308.
   PubMedGoogle Scholar
• Cubitt, H.E., Houston, J.B., and Galetin, A., 2011. Prediction of human drug clearance by multiple metabolic pathways: Integration of hepatic and intestinal microsomal and cytosolic data. Drug metabolism and disposition, 39 (5), 864–873.
   PubMed Web of Science ®Google Scholar
• Cui, D., et al., 2004. Heterotropic modulation of sulfotransferase 2A1 activity by celecoxib: product ratio switching of ethynylestradiol sulfation. Drug metabolism and disposition, 32 (11), 1260–1264.
   PubMed Web of Science ®Google Scholar
• Daniels, J., and Kadlubar, S., 2014. Pharmacogenetics of SULT1A1. Pharmacogenomics, 15 (14), 1823–1838.
   PubMed Web of Science ®Google Scholar
• Daniels, J., and Kadlubar, S., 2013. Sulfotransferase genetic variation: from cancer risk to treatment response. Drug metabolism reviews, 45 (4), 415–422.
   PubMed Web of Science ®Google Scholar
• Di Michele, F., et al., 2013. Neurosteroid and neurotransmitter alterations in Parkinson’s disease. Frontiers in neuroendocrinology, 34 (2), 132–142.
   PubMed Web of Science ®Google Scholar
• Duanmu, Z., et al., 2006. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. The journal of pharmacology and experimental therapeutics, 316 (3), 1310–1317.
   PubMed Web of Science ®Google Scholar
• Duanmu, Z., et al., 2002. Effects of dexamethasone on Aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug metabolism and disposition, 30 (9), 997–1004.
   PubMed Web of Science ®Google Scholar
• Duffel, M.W., et al., 2001. Enzymatic aspects of the phenol (Aryl) sulfotransferases. Drug metabolism reviews, 33, 369–395.
   PubMed Web of Science ®Google Scholar
• Eagle, K., 2014. ADHD impacted by sulfotransferase (SULT1A) inhibition from artificial food colors and plant-based foods. Physiology and behavior, 135, 174–179.
   PubMed Web of Science ®Google Scholar
• Eagle, K., 2012. Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines. Food & chemical toxicology, 50 (6), 2243–2249.
   PubMed Web of Science ®Google Scholar
• Falany, C.N., 1997. Enzymology of human cytosolic sulfotransferases. FASEB journal, 11, 206–216.
   PubMed Web of Science ®Google Scholar
• Falany, C.N., et al., 1994. Steroid sulfation by expressed human cytosolic sulfotransferases. The journal of steroid biochemistry and molecular biology, 48 (4), 369–375.
   PubMed Web of Science ®Google Scholar
• Falany, C.N. and Rohn-Glowacki, K.J., 2013. SULT2B1: unique properties and characteristics of a hydroxysteroid sulfotransferase family. Drug metabolism reviews, 45 (4), 388–400.
   PubMed Web of Science ®Google Scholar
• Falany, J.L., et al., 2002. Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis. Biochemical journal, 364(Pt1), 115–120.
   Web of Science ®Google Scholar
• Falany, J.L., Macrina, N., and Falany, C.N., 2004. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. Journal of steroid biochemistry and molecular biology, 88 (4–5), 383–391.
   PubMed Web of Science ®Google Scholar
• Fang, J., et al., 2016. Human sulfotransferases enhance the cytotoxicity of tolvaptan. Toxicological sciences, 150 (1), 27–39.
   Web of Science ®Google Scholar
• Fujita, K., et al., 1997. Molecular cloning and characterization of Rat ST1B1 and human ST1B2 cDNAs, encoding thyroid hormone sulfotransferases. Journal of biochemistry, 122, 1052–1061.
   PubMed Web of Science ®Google Scholar
• Gamage, N., 2005. Human sulfotransferases and their role in chemical metabolism. Toxicological sciences, 90 (1), 5–22.
   PubMed Web of Science ®Google Scholar
• Geese, W., and Raftogianis, R., 2001. Biochemical characterization and tissue distribution of human SULT2B1. Biochemical and biophysical research communication, 288, 280–289.
   PubMed Web of Science ®Google Scholar
• Gitlin, N., et al., 1998. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Annals of internal medicine, 129 (1), 36–38.
   PubMed Web of Science ®Google Scholar
• Glatt, H., 2000. Sulfotransferases in the bioactivation of xenobiotics. Chemico-biological interactions, 129 (1-2), 141–170.
   PubMed Web of Science ®Google Scholar
• Glatt, H., and Meinl, W., 2004. Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn-Schmiedeberg’s archives of pharmacology, 369 (1), 55–68.
   PubMed Web of Science ®Google Scholar
• Glatt, H., et al., 2001. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutation research, 482 (1–2), 27–40.
   PubMed Web of Science ®Google Scholar
• Gong, H., et al., 2008. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer research, 68 (18), 7386–7393.
   PubMed Web of Science ®Google Scholar
• Habuchi, O., 2000. Diversity and functions of glycosaminoglycan sulfotransferases. Biochimica et Biophysica Acta - general subjects, 1474, 115–127.
   PubMed Web of Science ®Google Scholar
• Hardwick, R.N., et al., 2013. Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver diseases. Drug metabolism and disposition, 41, 554–561.
   PubMed Web of Science ®Google Scholar
• Hebbring, S.J., et al., 2007. Human SULT1A1 gene: copy number differences and functional implications. Human molecular genetics, 16 (5), 463–470.
   PubMed Web of Science ®Google Scholar
• Hebbring, S.J., Moyer, A.M., and Weinshilboum R.M., 2008. Sulfotransferase gene copy number variation: pharmacogenetics and function. Cytogenetic and genome research, 123 (1–4), 205–210.
   PubMed Web of Science ®Google Scholar
• Her, C., et al., 1998. Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics, 53 (3), 284–295.
   PubMed Web of Science ®Google Scholar
• Hildebrandt, M.A.T., et al., 2004. Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Biochemical and biophysical research communications, 321 (4), 870–878.
   PubMed Web of Science ®Google Scholar
• Hildebrandt, M.A.T., et al., 2007. Genetic diversity and function in the human cytosolic sulfotransferases. The pharmacogenomics journal, 7 (2), 133–143.
   PubMed Web of Science ®Google Scholar
• Hodgson, J., 2001. ADMET-turning chemicals into drugs. Nature biotechnology, 19 (8), 722–726.
   PubMed Web of Science ®Google Scholar
• Honma, W., et al., 2002. Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver. Drug metabolism and disposition, 30 (8), 944–949.
   PubMed Web of Science ®Google Scholar
• Huang, J., et al., 2010. Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1). Xenobiotica, 40 (3), 184–194.
   PubMed Web of Science ®Google Scholar
• Hui, Y., et al., 2015. Sulfation of afimoxifene, endoxifen, raloxifene, and fulvestrant by the human cytosolic sulfotransferases (SULTs): a systematic analysis. Journal of pharmacological sciences, 128 (3), 144–149.
   PubMed Web of Science ®Google Scholar
• Ihunnah, C.A., et al., 2014. Estrogen sulfotransferase (EST/SULT1E1) promotes human adipogenesis. Molecular and cellular biology, 34 (9), 1682–1694.
   PubMed Web of Science ®Google Scholar
• James, M.O., 2014. Enzyme kinetics of conjugating enzymes: PAPS sulfotransferase. In: S. Nagar, U.A. Argikar and D.J. Tweedie, eds. Enzyme kinetics in drug metabolism. Fundamentals and applications. New York: Humana Press, 187–201.
   Google Scholar
• James, M.O. and Ambadapadi, S., 2013. Interactions of cytosolic sulfotransferases with xenobiotics. Drug metabolism reviews, 45 (4), 401–414.
   PubMed Web of Science ®Google Scholar
• Jancova, P., Anzenbacher, P., and Anzenbacherova, E., 2010. Phase II drug metabolizing enzymes. Biomedical papers, 154 (2), 103–116.
   PubMed Web of Science ®Google Scholar
• Jancova, P. and Šiller, M., 2012. Phase II drug metabolism. In: J. Paxton, ed. Topics on drug metabolism. Rijeka, Croatia: InTech, 35–60.
   Google Scholar
• Jiang, Y.J., 2005. LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes. The journal of lipid research, 46 (12), 2657–2666.
   PubMed Web of Science ®Google Scholar
• Kim, M.S., et al., 2004. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. American journal of physiology endocrinology and metabolism, 287 (4), E731–E738.
   Web of Science ®Google Scholar
• Klaassen, C.D., and Boles, W., 1997. Sulfation and sulfotransferases 5: the importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation. Faseb journal, 11, 404–418.
   PubMed Web of Science ®Google Scholar
• Kodama, S., et al., 2011. Liganded pregnane X receptor represses the human sulfotransferase SULT1E1 promoter through disrupting its chromatin structure. Nucleic acids research, 39 (19), 8392–8403.
   PubMed Web of Science ®Google Scholar
• Kurogi, K., et al., 2014. Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis. European journal of pharmaceutical sciences, 62, 40–48.
   PubMed Web of Science ®Google Scholar
• Li, W., et al., 2014. 17 -Estradiol induces sulfotransferase 2A1 expression through estrogen receptor. Drug metabolism and disposition, 42 (4), 796–802.
   PubMed Web of Science ®Google Scholar
• Luo, L., et al., 2016. Human cytosolic sulfotransferase SULT1C4 mediates the sulfation of doxorubicin and epirubicin. Drug metabolism and pharmacokinetics, 31 (2), 163–166.
   PubMed Web of Science ®Google Scholar
• Marinho, A.T., et al., 2014. Differences in nevirapine biotransformation as a factor for its sex-dependent dimorphic profile of adverse drug reactions. Journal of antimicrobial chemotherapy, 69 (2), 476–482.
   PubMed Web of Science ®Google Scholar
• Meloche, C.A., et al., 2002. Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST). Drug metabolism and disposition, 30 (5), 582–585.
   PubMed Web of Science ®Google Scholar
• Mercer, K.E., et al., 2010. Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis. International journal of molecular epidemiology and genetics, 1 (2), 92–103.
   PubMedGoogle Scholar
• Mueller, J.W., et al., 2015. The regulation of steroid action by sulfation and desulfation. Endocrine reviews, 36 (5), 526–563.
   PubMed Web of Science ®Google Scholar
• Nagar, S., Walther, S., and Blanchard, R.L., 2006. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Molecular pharmacology, 69 (6), 2084–2092.
   PubMed Web of Science ®Google Scholar
• Niehues, M., et al., 2015. Human sulfotransferase (SULT) reaction phenotyping of tedizolid. In: 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015), 25–28 April 2015. Copenhagen, Denmark.
   Google Scholar
• Nilsson, E., et al., 1994. Blood dehydroepiandrosterone sulphate (DHEAS) levels in polymyalgia rheumatica/giant cell arteritis and primary fibromyalgia. Clinical and experimental rheumatology, 12 (4), 415–417.
   PubMed Web of Science ®Google Scholar
• Nowell, S., et al., 2002. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. Cancer spectrum knowledge environment, 94 (21), 1635–1640.
   Google Scholar
• Nowell, S. and Falany, C.N., 2006. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene, 25 (11), 1673–1678.
   PubMed Web of Science ®Google Scholar
• Pacifici, G.M., 2005. Sulfation of drugs and hormones in mid-gestation human fetus. Early human development, 81 (7), 573–581.
   PubMed Web of Science ®Google Scholar
• Pacifici, G.M. & Coughtrie, M.W.H. eds., 2005. Human cytosolic sulfotransferases. Boca Raton: CRC Press.
   Google Scholar
• Pasqualini, J. and Chetrite, G., 2005. Estrogen sulfotransferase in breast cancer. In: G.M. Pacifici & M.W.H. Coughtrie, eds. Human cytosolic sulfotransferases. Boca Raton: CRC Press, 135–157.
   Google Scholar
• Pinheiro, P.F., et al., 2017. Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study. Archives of toxicology, 91 (3), 1199–1211.
   PubMed Web of Science ®Google Scholar
• Raftogianis, R.B., Wood, T.C., and Weinshilboum, R.M., 1999. Human phenol sulfotransferases SULT1A2 and SULT1A1 genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochemical pharmacology, 58 (4), 605–616.
   PubMed Web of Science ®Google Scholar
• Richard, K., et al., 2001. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. The journal of clinical endocrinology and metabolism, 86 (6), 2734–2742.
   PubMed Web of Science ®Google Scholar
• Riches, Z., et al., 2009. Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT “pie. Drug metabolism and disposition, 37 (11), 2255–2261.
   PubMed Web of Science ®Google Scholar
• Rogers, S., et al., 1987. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol. British journal of clinical pharmacology, 23 (6), 721–725.
   PubMed Web of Science ®Google Scholar
• Rohn, K.J., et al., 2012. Potent inhibition of human sulfotransferase (SULT) 1A1 by 17alpha-Ethinylestradiol (EE2): role of 3’-phosphoadenosine 5’-phosphosulfate (PAPS) binding and structural rearrangements in regulating inhibition and activity. Drug metabolism reviews, 40 (8), 1588–1595.
   Web of Science ®Google Scholar
• Runge-Morris, M. and Falany, C., 2013. Emerging insights into the function and regulation of the cytosolic sulfotransferases. Preface. Drug metabolism reviews, 45 (4), 387.
   PubMed Web of Science ®Google Scholar
• Runge-Morris, M. and Kocarek, T.A., 2009. Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs. PPAR research, 2009, 728941.
   PubMed Web of Science ®Google Scholar
• Runge-Morris, M. and Kocarek, T. a., 2013. Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity. Drug Metabolism reviews, 45 (4), 450–459.
   PubMed Web of Science ®Google Scholar
• Runge-Morris, M., Kocarek, T.A., and Falany, C.N., 2013. Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug metabolism reviews, 45 (1), 15–33.
   PubMed Web of Science ®Google Scholar
• Schwaninger, A.E., et al., 2011. Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases. Toxicology letters, 202 (2), 120–128.
   PubMed Web of Science ®Google Scholar
• Senggunprai, L., Yoshinari, K., and Yamazoe, Y., 2009. Selective role of sulfotransferase 2A1 (SULT2A1) in the N-sulfoconjugation of quinolone drugs in humans. Drug metabolism and disposition: the biological fate of chemicals, 37 (8), 1711–1717.
   PubMed Web of Science ®Google Scholar
• Seo, Y.-K., et al., 2013. SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer. Molecular endocrinology, 27 (6), 925–939.
   PubMed Web of Science ®Google Scholar
• Sharma, A.M., et al., 2013. 12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash. Chemical research in toxicology, 26 (5), 817–827.
   PubMed Web of Science ®Google Scholar
• Shibutani, S., et al., 1998. Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts. Carcinogenesis research, 58 (4), 647–653.
   Google Scholar
• Sim, S.C., Kacevska, M., and Ingelman-Sundberg, M., 2013. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects. The pharmacogenomics journal, 13 (1), 1–11.
   PubMed Web of Science ®Google Scholar
• Song, C.S., et al., 2001. Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. Journal of biological chemistry, 276 (45), 42549–42556.
   PubMed Web of Science ®Google Scholar
• Song, W.C., 2006. Biochemistry and reproductive endocrinology of estrogen sulfotransferase. Annals of the New York academy of sciences, 948 (1), 43–50.
   Google Scholar
• Song, W.C., Qian, Y., and Li, A.P., 1998. Estrogen sulfotransferase expression in the human liver: marked interindividual variation and lack of gender specificity. The journal of pharmacology and experimental therapeutics, 284 (3), 1197–1202.
   PubMed Web of Science ®Google Scholar
• Sonoda, J., et al., 2002. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proceedings of the national academy of sciences of the United States of America, 99 (21), 13801–13806.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2016a. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen. Acta pharmacologica sinica, 37 (6), 845–856.
   PubMed Web of Science ®Google Scholar
• Wang, L.-Q., and James, M.O., 2006. Inhibition of sulfotransferases by xenobiotics. Current drug metabolism, 7 (1), 83–104.
   PubMed Web of Science ®Google Scholar
• Wang, T., Cook, I., and Leyh, T.S., 2014. 3’-Phosphoadenosine 5’-phosphosulfate allosterically regulates sulfotransferase turnover. Biochemistry, 53 (44), 6893–6900.
   PubMed Web of Science ®Google Scholar
• Wang, Z., et al., 2016b. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury. Archives of toxicology, 91 (1), 271–287.
   PubMed Web of Science ®Google Scholar
• Watkins, P., 2005. Idiosyncratic liver injury: challenges and approaches. Toxicologic pathology, 33 (1), 1–5.
   PubMed Web of Science ®Google Scholar
• Waxman, D.J. and Holloway, M.G., 2009. Sex differences in the expression of hepatic drug metabolizing enzymes. Molecular pharmacology, 76 (2), 215–228.
   PubMed Web of Science ®Google Scholar
• Wilkinson, G.R., 2005. Drug metabolism and variability among patients in drug response. The new England journal of medicine, 352 (21), 2211–2221.
   PubMed Web of Science ®Google Scholar
• Xiao, J., et al., 2014. Sulfotransferase SULT1A1 Arg213His polymorphism with cancer risk: a meta-analysis of 53 case-control studies. PloS One, 9 (9), e106774.
   PubMed Web of Science ®Google Scholar
• Xu, Z.-H., et al., 2003. Pharmacogenetics of human 3′-phosphoadenosine 5′-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics. Biochemical pharmacology, 65 (11), 1787–1796.
   PubMed Web of Science ®Google Scholar
• Xu, Z.H., et al., 2000. Human 3’-phosphoadenosine 5’-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization. Biochemical and biophysical research communications, 268 (2), 437–444.
   PubMed Web of Science ®Google Scholar
• Yalcin, E., et al., 2016. Bisphenol A sulfonation is impaired in metabolic and liver disease. Toxicology and applied pharmacology, 292, 75–84.
   PubMed Web of Science ®Google Scholar
• Yalcin, E.B., et al., 2013. Downregulation of sulfotransferase expression and activity in diseased human livers. Drug metabolism and disposition: the biological fate of chemicals, 41 (9), 1642–1650.
   PubMed Web of Science ®Google Scholar
• Yamamoto, A., et al., 2015. Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. Journal of biochemistry, 158 (6), 497–504.
   PubMed Web of Science ®Google Scholar
• Yanai, H., 2003. Expression of cholesterol sulfotransferase (SULT2B1b) in human platelets. Circulation, 109 (1), 92–96.
   PubMed Web of Science ®Google Scholar
• Yao-Borengasser, A., et al., 2014. Sulfotransferase 1A1 (SULT1A1) gene expression is regulated by members of the NFI transcription factors in human breast cancer cells. BMC clinical pathology, 14 (1), 1.
   PubMedGoogle Scholar
• Yokoi, T., 2010. Troglitazone. In: J. Uetrecht, ed. Adverse drug reactions. Handbook of experimental pharmacology. Berlin Heidelberg: Springer, 419–435.
   Google Scholar
• Yu, X., et al., 2010. Functional genetic variants in the 3’-Untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicological sciences, 118 (2), 391–403.
   PubMed Web of Science ®Google Scholar
• Yu, X., et al., 2013. Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects. Pharmacogenomics and personalized medicine, 6 (1), 19–24.
   PubMedGoogle Scholar
• Zanger, U.M. and Schwab, M., 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology and therapeutics, 138 (1), 103–141.
   PubMed Web of Science ®Google Scholar
• Zhang, H., et al., 2007. Pharmacokinetic drug interactions involving 17α-ethinylestradiol: a new look at an old drug. Clinical pharmacokinetics, 46 (2), 133–157.
   PubMed Web of Science ®Google Scholar